13F Holdings
中文EN

SHFH Scientist Home Future Health Ltd

Perfumes, Cosmetics & Other Toilet Preparations · OTC · SEC CIK 2032609 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-265.8%
TTM EPS YoY-402.6%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin42.3%
Operating margin-60.2%
Net margin-60.2%
FCF margin—
EBITDA margin-58.0%

Returns

ROE-364.9%
ROA-51.8%
ROIC (approx.)—
Asset turnover0.86x

Leverage & solvency

Liabilities / assets112.9%
Debt / equity—
Current ratio0.53x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.78x
Accruals ratio-11.5%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31
Income statement
Revenue$204,055
Cost of revenue$122,168
Gross profit$81,887
SG&A expense$313,612
Operating income-$231,725
Pretax income-$231,725
Income tax$0
Net income-$231,725
EBITDA-$230,011
EPS (diluted)-0.01
Weighted avg. shares (diluted)23.59M
Banking
Deposits$48,417
Balance sheet
Cash & equivalents$68,888
Inventory$34,006
Current assets$192,246
PP&E, net$73,175
Total assets$644,365
Current liabilities$214,458
Total liabilities$530,974
Shareholders' equity$113,391
Shares outstanding23.72M
Cash flow statement
Operating cash flow-$248,278
Capital expenditure$74,774
Free cash flow-$323,052
Investing cash flow-$74,774
Financing cash flow$376,140
Depreciation & amortization$1,714

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.